Page last updated: 2024-11-13

levomefolate calcium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

levomefolate calcium: an ingredient in Contraceptives, Oral, Combined [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

levomefolate calcium : An organic calcium salt of (6S)-5-methyltetrahydrofolic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID135564391
CHEMBL ID1615371
CHEBI ID189695
MeSH IDM0570045

Synonyms (66)

Synonym
AC-7457
deplin
calcium levomefolate
levomefolinate calcium
151533-22-1
levomefolate calcium (usan)
D09354
metafolin (tn)
levomefolate calcium
bay 86-7660
(6s)-5-methyltetrahydrofolic acid calcium salt
metafolin
CHEBI:189695 ,
l-methylfolate calcium
bay86-7660
nutrifolin
bodyfolin
calcium (2s)-2-[4-({[(6s)-2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzamido]pentanedioate
l-glutamic acid, n-(4-((((6s)-2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-, calcium salt (1:1)
calcium n-(4-((((6s)-2-amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzoyl)-l-glutamate
levomefolate calcium [usan]
unii-a9r10k3f2f
a9r10k3f2f ,
n-(4-(((2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-l-glutamic acid calcium salt
CHEMBL1615371
extrafolate-s
l-methylfolate-calcium
ndi 638
l-5-mthf-ca
calcium l-methylfolate
lmc-a
lmca
l-5-methyletrahydrofolate calcium
HY-17383
levomefolate (calcium)
CS-1066
levomefolate calcium [orange book]
l-5-methyltetrahydrofolate calcium ,
levomefolate calcium component of beyaz
calcium l-5-methyltetrahydrofolate [dsc]
calcium l-5-methyltetrahydrofolate
ndi 638 [fdms]
l-5-methyltetrahydrofolic acid, calcium salt
beyaz component levomefolate calcium
calcium levomefolate [who-dd]
6(s)-5-methyltetrahydrofolic acid, calcium salt [ndi]
levomefolate calcium component of safyral
levomefolate calcium [vandf]
calcium levomefolate [mart.]
safyral component levomefolate calcium
129025-21-4
AKOS025117256
(s)-2-(4-((((s)-2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, calcium salt
AKOS025402270
mfcd18642975
calcium (2s)-2-{[4-({[(6s)-2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioate
GS-6017
calcium (4-((((s)-2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzoyl)-l-glutamate
calcium;(2s)-2-[[4-[[(6s)-2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate
Q27273818
l-5-methyl tetrahydrofolic
calcium;(2s)-2-[[4-[[(6s)-2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate
(s)-2-(4-((((s)-2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioicacid,calciumsalt
denovo
calcium levomefolate (mart.)
calcium (2s)-2-(4-((((6s)-2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The bioavailability of EE and drospirenone was similar after administration of EE/drospirenone/levomefolate calcium and EE/drospirenone."( Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone.
Blode, H; Diefenbach, K; Eydeler, U; Richard, F; Rohde, B; Trummer, D; Wiesinger, H, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antidepressantAntidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic calcium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (44.44%)5.53%
Reviews5 (55.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other0 (0.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]